Drug data will be more transparent, vows GSK
Ahead of his speech today, GSK CEO Sir Andrew Witty, pledges to make the company’s clinical trials data more open in order to help tackle worldwide healthcare problems. GSK is to further advance its commitment towards transparency, openness and collaboration, as these…